EUROQOL | News
EuroQol launches a new whiteboard animation, ‘Translating patient reported outcome measures for use around the world: the example of EQ-5D’
EuroQol is proud to announce the launch of a new whiteboard animation 'Translating patient reported outcome measures for use around the world: the example of EQ-5D’ , providing a step-by-step overview of how to translate…
Study team appointed for the new UK EQ-5D-5L valuation study
The research team for the new EQ-5D-5L valuation study for the United Kingdom has been finalised. This team will bring significant experience and expertise to the valuation study. They were carefully selected by the project’s…
EQ-5D is the most commonly cited multi-attribute utility instrument in review of national pharmacoeconomic guidelines
A review identifying which multi-attribute utility instruments (MAUIs) are recommended for use in official national pharmacoeconomic (PE) guidelines has been published in the European Journal of Health Economics. The study reviewed PE guidelines where health…
First EuroQol approved sign language version of the EQ-5D-5L is now available
EuroQol is pleased to announce the release of the British Sign Language (BSL) version of the EQ-5D-5L instrument. This is the first sign language version that has been approved by EuroQol. The EuroQol Board and…
The 2nd EuroQol Asia Academy Meeting is postponed until 2021
In light of current situation of the Covid-19 in around the globe, where some countries (e.g., Singapore) are having second wave and in some others (e.g., Indonesia, Malaysia, India) the measures being implemented by the…
Chinese version of the EQ-5D-5L User Guide now available for download
The EuroQol Office is pleased to announce that the EQ-5D-5L User Guide is now available in Chinese (Mandarin). The User Guide provides readers with basic information on how to use the EQ-5D-5L questionnaire. Topics include…
International valuation protocol for the EQ-5D-Y published
EuroQol is pleased to announce that, following an extensive programme of methodological research, an international evidence-based valuation protocol has been developed for the EQ-5D-Y instrument. Published in PharmacoEconomics, the new valuation protocol will enable the…
EQ-5D licenses for COVID-19 related research
EuroQol is committed to improve decisions about health and health care throughout the world by making available EQ-5D for research on the impact of COVID-19. The EQ Office Team is handling all requests for using…
Notice to website visitors and customers
As a result of the Covid-19 crisis the EuroQol Office team is working from home. We are doing our best to guarantee the level of service that you have become accustomed to. However, the current…
Extending deadline Call for Abstracts for the 37th EQ Plenary Meeting 2020 in Chicago
In light of the Covid-19 crisis emerging worldwide, we kindly inform you that the deadline for submitting abstracts for the 37th EuroQol Plenary Meeting on 16-19 September 2020 in Chicago is postponed to Monday 11…